Bhelliom to Launch a New Sustained-Release Energy Pill For Convenience Stores Nationwide

A study conducted by the Rush University Medical Center, Brigham, Women’s Hospital and Harvard Medical School revealed that if caffeine is consumed in low doses throughout the day, then a person can effectively stay awake and alert for longer periods of time.

Research funded by the US Air Force Office of Scientific Researches shows low doses of caffeine every hour are a much more effective way to administer caffeine than one large dose. In military studies, researchers studied subjects given caffeine equivalent to one ounce of coffee every hour verses those who were given a large single dose. The studies revealed that small doses given every hour were undoubtedly more effective then one or two large cups of coffee.

The results of this research contradicts the way the average American uses coffee, caffeine, energy drinks, and energy pills. Americans are conditioned to use one big dose. While there is no doubt the large dose of caffeine can be effective short term, it is usually followed by a significant crash as the caffeine wears off, often leaving the user more tired than they started.

“I hate to say it, but most of the population is using caffeine the wrong way by drinking a few mugs of coffee or tea in the morning.”said James K. Wyatt, PhD at Rush University Medical Center in Chicago, the study's lead researcher.

Bhelliom Enterprises a leader in the nutraceutical marketplace is about to unleash a new energy pill that goes hand in hand with this exciting new research. Bhelliom's team has created an energy pill that combines caffeine with other energy igniting herbs to provide a powerful steady flow of refreshing energy, that lasts all day.

Bhelliom is set to launch it's new sustained release energy pill on December 1, 2006. With a market like the US where consumers are overwhelmed with the fast pace and always changing environment, Bhelliom's new energy product is poised to become a big winner.

“We are extremely excited to launch our new sustained release energy product. With the void left in the marketplace by the heavy regulations placed on OTC Ephedrine products, consumers and store-owners alike are scrambling to find a suitable replacement. We are that replacement.” states Casey McCarthy, CEO of Bhelliom Enterprises.

Further information on this exciting development is available at www.bhelliom.com.


###